Watson 372 50 mg (Loxapine 50 mg)

Pill imprint Watson 372 50 mg has been identified as Loxapine succinate 50 mg.

Loxapine is used in the treatment of agitation; schizophrenia and belongs to the drug class miscellaneous antipsychotic agents. FDA has not classified the drug for risk during pregnancy. Loxapine 50 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for Watson 372 50 mg (Loxapine 50 mg)

Loxapine succinate 50 mg Watson 372 50 mg
Loxapine succinate 50 mg Watson 372 50 mg
Loxapine succinate
Imprint:
Watson 372
50 mg
Strength:
50 mg
Color:
Blue & White
Size:
19.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Miscellaneous antipsychotic agents
Pregnancy Category:
N - Not classified
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Watson Laboratories, Inc.
National Drug Code (NDC):
00591-0372
Inactive Ingredients:
lactose anhydrous
benzyl alcohol
butylparaben
edetate calcium disodium
gelatin
magnesium stearate
methylparaben
polacrilin potassium
propylparaben
sodium lauryl sulfate
sodium propionate
magnesium silicate
titanium dioxide
FD&C Blue No. 1
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
51079-0903 UDL Laboratories Inc

Note: Inactive ingredients may vary.

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Hide
(web1)